SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Ian@SI who wrote (4483)8/15/2001 5:41:33 PM
From: Biomaven  Read Replies (1) | Respond to of 52153
 
Ian,

would have expected it to at least have some of the clinical trial sites in the US

It most certainly does have US sites in its Phase III, as well as some in Canada, US and South Africa.

Why do you assume it didn't consult with the FDA before its Phase III? It did - the FDA has kept a very tight rein on all clinical trials of blood substitutes.

Peter